RÉSUMÉ
Temporomandibular joint osteoarthritis (TMJ OA) is characterized by the degeneration of cartilage and subchondral bone. In this study, we observed a significant increase in cell-free DNA (cfDNA) levels during the progression of TMJ OA. Bioinformatics analysis identified TLR9 as a pivotal molecule in TMJ OA pathogenesis. The polyamidoamine (PAMAM) dendrimer characterized by a well-structured, highly branched, and reactive nature, exhibits robust binding and clearance capabilities for cfDNA. However, the abundant amino groups on the surface of PAMAM lead to its inherent toxicity. To mitigate this, PEG-5000 was conjugated to the surface of PAMAM dendrimers, enhancing safety. Our results indicate that PEG-PAMAM effectively inhibits the upregulation of the TLR9 protein in TMJ OA, significantly suppressing the activation of the p-IκBα/p-NF-κB signaling pathway and subsequently decreasing chondrocyte inflammation and apoptosis, as evidenced by both in vivo and in vitro experiments. We conclude that PEG-PAMAM is a safe and effective material for in vivo applications, offering a promising therapeutic strategy for TMJ OA by targeting cfDNA clearance.
Sujet(s)
Acides nucléiques acellulaires , Dendrimères , Arthrose , Polyéthylène glycols , Articulation temporomandibulaire , Dendrimères/composition chimique , Dendrimères/pharmacologie , Arthrose/traitement médicamenteux , Arthrose/anatomopathologie , Arthrose/métabolisme , Animaux , Polyéthylène glycols/composition chimique , Articulation temporomandibulaire/anatomopathologie , Articulation temporomandibulaire/effets des médicaments et des substances chimiques , Articulation temporomandibulaire/métabolisme , Adsorption , Humains , Récepteur-9 de type Toll-like/métabolisme , Mâle , Chondrocytes/effets des médicaments et des substances chimiques , Chondrocytes/métabolisme , Nylons/composition chimique , Nylons/pharmacologie , Apoptose/effets des médicaments et des substances chimiques , SourisRÉSUMÉ
Carpet cleaning guidelines currently do not include the use of an antimicrobial, except after a bodily fluid event. To address this gap, we compared the efficacy of three antimicrobials-two hydrogen peroxide-based (H2O2) products (A and B) and one chlorine-based product (C)-and a steam treatment against two norovirus surrogates, specifically feline calicivirus (FCV) and Tulane virus (TuV). These tests were performed on nylon carpets with either water-permeable or waterproof backing types. The effect of repeated antimicrobial use on carpet properties was also evaluated. For a carpet with water-permeable backing, products A, B, and C achieved a 0.8, 3.1, and 0.9 log10 PFU/coupon reduction of FCV and 0.3, 2.5, and 0.4 log10 TCID50/coupon reduction of TuV, respectively, following a 30 min contact time. For carpet with waterproof backing, only product B achieved a 5.0 log10 PFU/coupon reduction of FCV and >3.0 log10 TCID50/coupon reduction of TuV, whereas products A and C achieved a 2.4 and 1.6 log10 PFU/coupon reduction of FCV and a 1.2 and 1.2 log10 TCID50/coupon reduction of TuV, respectively. Steam treatment achieved a ≥ 5.2 log10 PFU/coupon reduction of FCV and a > 3.2 log10 TCID50/coupon reduction of TuV in 15 seconds on the carpet with both backing types. The repeated use of products A and B decreased the tensile strength of the carpet backing, while use of product B resulted in cracks on carpet fibers. Overall, steam treatment for 15 seconds was efficacious on both carpet types, but only product B achieved efficacy after a 30-minute exposure on the carpet with waterproof backing.IMPORTANCECarpets are common in long-term care facilities, despite its potential as a vehicle for transmission of agents associated with healthcare-associated infections, including human norovirus (NoV). Presently, our understanding of carpet disinfection is limited; hence, there are no commercial antimicrobials against norovirus available for use on carpets. Our findings showed that steam treatment, which minimally affected the properties of carpet fibers and backing, was more efficacious against human norovirus surrogates on carpets compared to the three chemical antimicrobials tested. Additionally, the two surrogates were more sensitive to chemical antimicrobials on the carpet with waterproof backing compared to carpets with water-permeable backing. These findings can inform development of antimicrobials for use on carpets contaminated with human norovirus.
Sujet(s)
Norovirus , Vapeur , Norovirus/effets des médicaments et des substances chimiques , Calicivirus félin/effets des médicaments et des substances chimiques , Animaux , Désinfectants/pharmacologie , Nylons/pharmacologie , Anti-infectieux/pharmacologie , Humains , Désinfection/méthodes , Peroxyde d'hydrogène/pharmacologie , États-Unis , Sols et revêtements , Environmental Protection Agency (USA) , Carpes (poisson)RÉSUMÉ
BACKGROUND: In this study, the antimicrobial activity of three different cleanser tablets on S. mutans and C. albicans adhesion to PMMA, polyamide and 3D printed resin was investigated. METHODS: 40 samples were prepared for PMMA (SR Triplex Hot), polyamide (Deflex) and 3D printed resin (PowerResins Denture) materials and divided into four subgroups for cleansers (Aktident™, Protefix™, Corega™ tablets and distilled water) (n = 5). After the surface preparations were completed, the samples were immersed separately in tubes containing the prepared microorganism suspension and incubated at 37ËC for 24 h. After the incubation, the samples were kept in the cleanser solutions. The samples were then transferred to sterile saline tubes. All the tubes were vortexed and 10 µl was taken from each of them. Sheep blood agar was inoculated for colony counting. The inoculated plates were incubated for 48 h for S. mutans and 24 h for C. albicans. After incubation, colonies observed on all plates were counted. Statistical analyses were done with three-way ANOVA and Tukey's multiple comparison test. RESULTS: Polyamide material registered the highest colony count of S. mutans, whereas PMMA registered the lowest. Significant differences in S. mutans adherence (p = 0.002) were found between the three denture base materials, but no such difference in C. albicans adherence (p = 0.221) was identified between the specimens. All three cleanser tablets eliminated 98% of S. mutans from all the material groups. In all these groups, as well, the antifungal effect of Corega™ on C. albicans was significantly higher than those of the other two cleanser tablets. CONCLUSIONS: According to the study's results, it may be better to pay attention to surface smoothness when using polyamide material to prevent microorganism retention. Cleanser tablets are clinically recommended to help maintain hygiene in removable denture users, especially Corega tablets that are more effective on C. albicans.
Sujet(s)
Candida albicans , Bases d'appareil de prothèse dentaire , Produits de nettoyage pour appareils de prothèse dentaire , Poly(méthacrylate de méthyle) , Streptococcus mutans , Candida albicans/effets des médicaments et des substances chimiques , Streptococcus mutans/effets des médicaments et des substances chimiques , Bases d'appareil de prothèse dentaire/microbiologie , Produits de nettoyage pour appareils de prothèse dentaire/pharmacologie , Poly(méthacrylate de méthyle)/composition chimique , Nylons/pharmacologie , Comprimés , Numération de colonies microbiennes , Matériaux dentaires/pharmacologie , Adhérence bactérienne/effets des médicaments et des substances chimiques , Anti-infectieux/pharmacologie , Test de matériauxRÉSUMÉ
Aberrant gene expression underlies numerous human ailments. Hence, developing small molecules to target and remedy dysfunctional gene regulation has been a long-standing goal at the interface of chemistry and medicine. A major challenge for designing small molecule therapeutics aimed at targeting desired genomic loci is the minimization of widescale disruption of genomic functions. To address this challenge, we rationally design polyamide-based multi-functional molecules, i.e., Synthetic Genome Readers/Regulators (SynGRs), which, by design, target distinct sequences in the genome. Herein, we briefly review how SynGRs access chromatin-bound and chromatin-free genomic sites, then highlight the methods for the study of chromatin processes using SynGRs on positioned nucleosomes in vitro or disease-causing repressive genomic loci in vivo.
Sujet(s)
Chromatine , Nucléosomes , Humains , Chromatine/génétique , Chromatine/métabolisme , Nucléosomes/génétique , Nucléosomes/métabolisme , Nylons/composition chimique , Nylons/pharmacologie , Régulation de l'expression des gènes/effets des médicaments et des substances chimiques , Animaux , Assemblage et désassemblage de la chromatine/effets des médicaments et des substances chimiques , Assemblage et désassemblage de la chromatine/génétique , Génomique/méthodesRÉSUMÉ
Piscirickettsiosis is the most prevalent bacterial disease affecting seawater salmon in Chilean salmon industry. Antibiotic therapy is the first alternative to counteract infections caused by Piscirickettsia salmonis. The presence of bacterial biofilms on materials commonly used in salmon farming may be critical for understanding the bacterial persistence in the environment. In the present study, the CDC Biofilm Reactor® was used to investigate the effect of sub- and over-MIC of florfenicol on both the pre-formed biofilm and the biofilm formation by P. salmonis under the antibiotic stimuli on Nylon and high-density polyethylene (HDPE) surfaces. This study demonstrated that FLO, at sub- and over-MIC doses, decreases biofilm-embedded live bacteria in the P. salmonis isolates evaluated. However, it was shown that in the P. salmonis Ps007 strain the presence of sub-MIC of FLO reduced its biofilm formation on HDPE surfaces; however, biofilm persists on Nylon surfaces. These results demonstrated that P. salmonis isolates behave differently against FLO and also, depending on the surface materials. Therefore, it remains a challenge to find an effective strategy to control the biofilm formation of P. salmonis, and certainly other marine pathogens that affect the sustainability of the Chilean salmon industry.
Sujet(s)
Maladies des poissons , Piscirickettsia , Infections à Piscirickettsiaceae , Salmonidae , Animaux , Polyéthylène/pharmacologie , Nylons/pharmacologie , Maladies des poissons/traitement médicamenteux , Maladies des poissons/prévention et contrôle , Maladies des poissons/microbiologie , Antibactériens/pharmacologie , Saumon , Biofilms , Infections à Piscirickettsiaceae/médecine vétérinaire , Infections à Piscirickettsiaceae/microbiologieRÉSUMÉ
PURPOSE: The DNA recognition peptide compounds pyrrole-imidazole (PI) polyamides bind to the minor groove and can block the binding of transcription factors to target sequences. To develop more PI polyamides as potential treatments for fibrotic diseases, including chronic renal failure, we developed multifunctional PI polyamides that increase hepatocyte growth factor (HGF) and decrease transforming growth factor (TGF)-ß1. METHODS: We designed seven PI polyamides (HGF-1 to HGF-7) that bind to the chicken ovalbumin upstream promoter transcription factor-1 (COUP-TF1) binding site of the HGF promoter sequence. We selected PI polyamides that increase HGF and suppress TGF-ß1 in human dermal fibroblasts (HDFs). FINDINGS: Gel shift assays showed that HGF-2 and HGF-4 bound the appropriate dsDNAs. HGF-2 and HGF-4 significantly inhibited the TGF-ß1 mRNA expression in HDFs stimulated by phorbol 12-myristate 13-acetate. HGF-2 and HGF-4 significantly inhibited the TGF-ß1 protein expression in HDFs with siRNA targeting HGF, indicating that HGF-2 and HGF-4 directly inhibited the expression of TGF-ß1. CONCLUSION: The designed and synthetic HGF PI polyamides targeting the HGF promoter, which increased the expression of HGF and suppressed the expression of TGF-ß, will be a potential practical medicine for fibrotic diseases, including progressive renal diseases.
Sujet(s)
Nylons , Facteur de croissance transformant bêta-1 , Humains , Nylons/composition chimique , Nylons/pharmacologie , Facteur de croissance des hépatocytes , Facteur de croissance transformant bêta/génétique , Pyrroles/pharmacologie , Pyrroles/composition chimique , Imidazoles/pharmacologie , Imidazoles/composition chimiqueRÉSUMÉ
Purpose: This study investigated the influence of three types of metallic microfillers, spherical silver and spherical, and dendritic copper, on the ability of polyamide 12 (PA12) to inhibit microorganism growth on the surfaces of samples produced using laser-based powder bed fusion of polymers (PBF-LB/P). The aim of this study was to initially characterize these materials regarding their potential applicability for parts dedicated to use in the hospitals, where surfaces are periodically disinfected using chemical and/or physical measures. Methods: Composite powders with filler concentrations of 0.5, 1, 2 and 5% by weight were prepared using the mechanical mixing method and processed using PBF-LB/P. Three common hospital pathogens responsible for healthcare-associated infections: Pseudomonas aeruginosa, Staphylococcus aureus and Candida albicans were tested. Additionally, the safety of the composites was assessed through in vitro tests using human cell lines: keratinocytes and fibroblasts. Results: The research reveals that addition of copper or silver causes decrease in bacterial colony viability compared to the material without a filler, but an insignificant effect on antifungal properties. There was no significant impact within the tested range of filler's content on the antibacterial properties. Furthermore, a strong effect of the microfillers on tested material's toxicity is observed. Conclusions: The addition of metallic microfillers enhances the antibacterial response of polymeric materials processed with PBF-LB/P. Nevertheless, the observed varying levels of cytotoxicity toward eukaryotic cell lines underscore the need for further studies on the analysed materials to unequivocally determine their potential applicability as materials for short-term contact with human skin in a hospital setting.